Enrique Roca

1.7k total citations
45 papers, 818 citations indexed

About

Enrique Roca is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Enrique Roca has authored 45 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 19 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Enrique Roca's work include Colorectal and Anal Carcinomas (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Colorectal Cancer Surgical Treatments (7 papers). Enrique Roca is often cited by papers focused on Colorectal and Anal Carcinomas (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Colorectal Cancer Surgical Treatments (7 papers). Enrique Roca collaborates with scholars based in Argentina, United States and Spain. Enrique Roca's co-authors include Éduardo Bruera, R. Chacón, L. Cedaro, Samuela Carraro, Mario Barugel, Guillermo Méndez, Eduardo Huertas, N Giacomi, Juan Manuel O’Connor and Matías Chacón and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

Enrique Roca

41 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enrique Roca Argentina 16 382 284 194 138 131 45 818
Edward Chow Canada 16 182 0.5× 429 1.5× 211 1.1× 148 1.1× 137 1.0× 39 822
Ki‐Wook Chung South Korea 10 210 0.5× 556 2.0× 106 0.5× 210 1.5× 62 0.5× 12 859
R Trèves France 18 94 0.2× 320 1.1× 147 0.8× 149 1.1× 42 0.3× 107 1.2k
Balazs Imre Bodai United States 18 199 0.5× 419 1.5× 209 1.1× 42 0.3× 44 0.3× 32 1.2k
Lalit Kumar India 12 129 0.3× 150 0.5× 97 0.5× 103 0.7× 45 0.3× 28 508
J. Carulla Spain 12 218 0.6× 119 0.4× 65 0.3× 213 1.5× 112 0.9× 22 608
Sanjeev Balu United States 15 144 0.4× 175 0.6× 39 0.2× 79 0.6× 76 0.6× 48 988
Divyanshoo R. Kohli United States 17 244 0.6× 419 1.5× 350 1.8× 70 0.5× 46 0.4× 65 875
Cameron I. Wells New Zealand 20 388 1.0× 717 2.5× 247 1.3× 149 1.1× 14 0.1× 74 1.2k
L. Rigo Italy 16 361 0.9× 596 2.1× 117 0.6× 220 1.6× 27 0.2× 23 1.1k

Countries citing papers authored by Enrique Roca

Since Specialization
Citations

This map shows the geographic impact of Enrique Roca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique Roca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique Roca more than expected).

Fields of papers citing papers by Enrique Roca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrique Roca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique Roca. The network helps show where Enrique Roca may publish in the future.

Co-authorship network of co-authors of Enrique Roca

This figure shows the co-authorship network connecting the top 25 collaborators of Enrique Roca. A scholar is included among the top collaborators of Enrique Roca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrique Roca. Enrique Roca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iseas, Soledad, Guillermo Méndez, Marcela Carballido, et al.. (2023). Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric Cohort. Biomedicines. 11(3). 791–791. 3 indexed citations
2.
Iseas, Soledad, Javier Mariani, Ana Cabanne, et al.. (2021). A clinical and molecular portrait of non-metastatic anal squamous cell carcinoma. Translational Oncology. 14(6). 101084–101084. 18 indexed citations
3.
Iseas, Soledad, Enrique Roca, Juan Manuel O’Connor, et al.. (2020). Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial. Investigational New Drugs. 38(5). 1580–1587. 6 indexed citations
4.
Roca, Enrique, et al.. (2020). Analysis of long-term oncological results of clinical versus pathological responses after neoadjuvant treatment in locally advanced rectal cancer. World Journal of Surgical Oncology. 18(1). 313–313. 12 indexed citations
5.
Shparyk, Yaroslav, Igor Bondarenko, Giovanni M. Bariani, et al.. (2018). Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial. ˜The œLancet. Gastroenterology & hepatology. 3(12). 845–855. 34 indexed citations
6.
7.
Iseas, Soledad, et al.. (2016). P-127 Pathological versus clinical complete responders after preoperative treatment in rectal cancer: long term outcomes analysis. Annals of Oncology. 27. ii37–ii37. 1 indexed citations
8.
Loria, Fernando Sánchez, Soledad Iseas, Juan Manuel O’Connor, et al.. (2016). Non-surgical management of rectal cancer. Series of 68 cases, long follow up in two leading centres in Argentina. Digestive and Liver Disease. 48(11). 1372–1377. 14 indexed citations
9.
Antelo, Marina, Jennifer Rhees, Enrique Roca, et al.. (2015). Pitfalls in the diagnosis of biallelic PMS2 mutations. Familial Cancer. 14(3). 411–414. 9 indexed citations
10.
11.
Kaen, Diego, Rubén Dario Kowalyszyn, Marcela Carballido, et al.. (2012). F-box and WD repeat domain-containing 7 (FBXW7) mRNA and outcome in biliary tract cancer.. Journal of Clinical Oncology. 30(15_suppl). e14521–e14521. 1 indexed citations
12.
Chen, Jen‐Shi, Yee Chao, Yung‐Jue Bang, et al.. (2010). A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinoma. Anti-Cancer Drugs. 21(8). 777–784. 17 indexed citations
13.
Cabanne, Ana, et al.. (2009). Immunohistochemical expression of somatostatin receptors in digestive endocrine tumours. Digestive and Liver Disease. 42(3). 220–225. 51 indexed citations
14.
Belli, Susana, Adriana Oneto, Juan Manuel O’Connor, et al.. (2009). Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina.. PubMed. 39(3). 184–9. 16 indexed citations
15.
Chacón, Matías, Enrique Roca, Mario Barugel, et al.. (2004). Report of solid cancer in patients (pts) with gastrointestinal stromal tumours (GIST). Journal of Clinical Oncology. 22(14_suppl). 9065–9065. 2 indexed citations
16.
Roca, Enrique, Eduardo J. Pennella, Silvia Carraro, et al.. (1996). Combined intensive chemoradiotherapy for organ preservation in patients with resectable and non-resectable oesophageal cancer. European Journal of Cancer. 32(3). 429–432. 19 indexed citations
17.
Humblet, Yves, et al.. (1996). Tallimustine in advanced previously untreated colorectal cancer, a phase II study. British Journal of Cancer. 73(6). 803–804. 24 indexed citations
18.
Cazap, Eduardo, et al.. (1988). Phase II trial of 4'-epi-doxorubicin in locally advanced or metastatic gastric cancer.. PubMed. 74(3). 313–5. 1 indexed citations
19.
Cazap, Eduardo, Roberto Estévez, M. Bruno, et al.. (1988). Phase II Trial of 4′-Epi-Doxorubicin in Locally Advanced or Metastatic Gastric Cancer. Tumori Journal. 74(3). 313–315. 3 indexed citations
20.
Filmus, Jorge, et al.. (1982). [Tartrate-resistant acid phosphatase in the detection of bone metastasis in patients with cancer].. PubMed. 42(6 Pt 1). 655–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward Chow Breakdown of academic impact, for papers by Ki‐Wook Chung Breakdown of academic impact, for papers by R Trèves Breakdown of academic impact, for papers by Balazs Imre Bodai Breakdown of academic impact, for papers by Lalit Kumar Breakdown of academic impact, for papers by J. Carulla Breakdown of academic impact, for papers by Sanjeev Balu Breakdown of academic impact, for papers by Divyanshoo R. Kohli Breakdown of academic impact, for papers by Cameron I. Wells Breakdown of academic impact, for papers by L. Rigo
Rankless by CCL
2026